supp.fit

Quercetin: study protocols

100 study groups say how much Quercetin participants took a day. These are the doses the studies gave. They are not a recommendation.

Quercetin: what the research found →

Dose per serving from products

2,084 products in our catalogue print how much Quercetin a serving holds.

Most common: 25 mg to 50 mg, 19% of 2,084 products.

Dose per servingProducts
5 mg or less
103
5 mg to 10 mg
81
10 mg to 25 mg
299
25 mg to 50 mg
394
50 mg to 100 mg
294
100 mg to 250 mg
328
250 mg to 500 mg
353
500 mg to 1 g
203
over 1 g
29

Dose per serving from research

97 study groups in 75 studies say how much Quercetin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 28% of 97 study groups.

Daily doseStudy groups
25 mg or less
4
25 mg to 50 mg
5
50 mg to 100 mg
6
100 mg to 250 mg
25
250 mg to 500 mg
23
500 mg to 1 g
27
1 g to 2.5 g
7

Commonly used together

27 of 100 study groups took Quercetin with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin C
14
Niacin
5
Green Tea Extract
4
Vitamin D
3

100 study groups

Study
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
2022 · Quercetin · Adults over 18 hospitalized in a non-ICU ward with severe COVID-19
1 g7 days30
Quercetin reduces illness but not immune perturbations after intensive exercise
2007 · quercetin · trained male cyclists; age and health condition not specified
1 g3 weeks20
The Adjunctive Effect of Quercetin on Postoperative Pain Management Following Cesarean Section: A Randomized Controlled Study
2025 · Quercetin group · Pregnant females over 18 years undergoing elective full-term cesarean section under spinal anesthesia
500 mg1 day40
The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial
2017 · quercetin group · Women with rheumatoid arthritis
500 mg8 weeks—
Quercetin's influence on exercise performance and muscle mitochondrial biogenesis
2010 · quercetin (Q) · Untrained young adult males, mean age 20.2 years
1 g2 weeks26
Quercetin Supplementation Improves Neuromuscular Function Recovery from Muscle Damage
2020 · Q supplementation · Healthy men, mean age 25.9 ± 3.3 years, without reported cardiac, metabolic, neurological or renal disease; low-to-moderate physical activity
1 g2 weeks16
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial
1999 · quercetin · Men with category IIIa or IIIb chronic pelvic pain syndrome
1 g30 days15
The effect of quercetin and citrulline on cycling time trial performance
2024 · QCT · Male and female trained, regularly competing cyclists aged 18–55 years
1 g4 weeks13
The Effects of Quercetin Supplementation on Eccentric Exercise-Induced Muscle Damage
2019 · Quercetin (Q) treatment · Moderately active men aged 26.1 ± 3.1 years undergoing an eccentric exercise protocol; no diagnosed condition reported
1 g2 weeks12
The acute effect of Quercetin on muscle performance following a single resistance training session
2018 · Quercetin · Young men, mean age 22.1 years; no diagnosed condition stated
1 g1 day10
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
2020 · 500 mg/day quercetin group · Adults aged 40–80 years with mild-to-moderate COPD and a smoking history of at least 10 pack-years
500 mg7 days2
The dietary flavonoid quercetin increases VO(2max) and endurance capacity
2010 · quercetin · healthy, untrained volunteers
1 g7 days—
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II
2019 · Lertal® Group (LG) · Children aged 6–12 years with allergic rhinoconjunctivitis and sensitization to house dust mites or pollens
150 mg12 weeks64
Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms
2013 · quercetin · healthy men with APOE genotypes 3/3, 3/4 or 4/4
150 mg8 weeks49
Effect of onion peel extract on endothelial function and endothelial progenitor cells in overweight and obese individuals
2015 · OPE group · Healthy overweight and obese individuals
100 mg12 weeks36
Enzymatically modified isoquercitrin improves endothelial function in volunteers at risk of cardiovascular disease
2020 · EMIQ® · Adults with at least one cardiovascular disease risk factor; 12 males and 13 females, ages not reported
2 mg/kg1 day25
Quercetin ingestion alters motor unit behavior and enhances improvement in muscle strength following resistance training in older adults: a randomized, double-blind, controlled trial
2025 · quercetin (QUE) group · Healthy, physically independent adults aged 65–82 years, male and female
200 mg6 weeks13
The effect of quercetin and citrulline on cycling time trial performance
2024 · QCT+CIT · Male and female trained, regularly competing cyclists aged 18–55 years
1 g4 weeks12
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
2020 · 1000 mg/day quercetin group · Adults aged 40–80 years with mild-to-moderate COPD and a smoking history of at least 10 pack-years
1 g7 days2
Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial
2009 · EMIQ group · People with Japanese cedar pollinosis; age and sex not specified
200 mg8 weeks—
Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis
2009 · EMIQ group · People with Japanese cedar pollinosis; age and sex not reported
100 mg8 weeks—
Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: a randomized, placebo-controlled, double-blind parallel-group study
2022 · quercetin-containing supplement group · Japanese adults aged 22–78 with allergic symptoms of pollinosis
200 mg4 weeks—
Effects of 7-day quercetin intervention on motor unit activity and muscle contractile properties before and after resistance exercise in young adults randomized controlled trials
2024 · quercetin glycosides (QUE) · young adult men and women; no specific condition stated
200 mg7 days—
Quercetin reduces blood pressure in hypertensive subjects
2007 · quercetin · Men and women with prehypertension or stage 1 hypertension
730 mg4 weeks41
Aloysia citriodora Palau (lemon verbena) for insomnia patients: A randomized, double-blind, placebo-controlled clinical trial of efficacy and safety
2019 · A. citriodora group · People with insomnia; age and sex not specified
3.22 mg4 weeks50
Effects of a Singular Dose of Mangiferin-Quercetin Supplementation on Basketball Performance: A Double-Blind Crossover Study of High-Level Male Players
2024 · EXP group, POST condition (mangiferin–quercetin) · Highly trained/national-level male basketball players aged over 18 years, representing the top three Greek national leagues
140 mg1 day19
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
2020 · 2000 mg/day quercetin group · Adults aged 40–80 years with mild-to-moderate COPD and a smoking history of at least 10 pack-years
2 g7 days2
Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study
2012 · GCQ supplement · Japanese subjects with symptomatic knee osteoarthritis
45 mg16 weeks—
The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metabolic Health in Overweight, Recreationally Active Individuals
2021 · dGTE+ · Adults over 18 who were recreationally active and overweight (BMI 25.0–29.9 kg/m² and/or body fat in the overweight category); healthy, without the listed cardio-metabolic or blood/liver disorders
50 mg8 weeks—
Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study
2009 · quercetin treatment · Overweight or obese adults aged 25–65 years with metabolic syndrome traits
150 mg6 weeks93
Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype
2010 · quercetin · Overweight-obese volunteers aged 25–65 years with metabolic syndrome traits; apoE3 and apoE4 subgroups were analyzed
150 mg6 weeks93
Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial
2015 · quercetin · Adults aged 25–65 years with overweight or obesity and pre-hypertension or stage I hypertension, with metabolic-syndrome traits
162 mg6 weeks70
Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide
2012 · quercetin · men: normotensive men aged 24 ± 3 years and men with stage 1 hypertension aged 41 ± 12 years
1.1 g1 day17
Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin
2019 · Treatment A (quercetin 500 mg) · Healthy adults aged 18–50 years, both sexes, without significant organic or psychiatric disease
500 mg1 day12
Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin
2019 · Treatment B (Quercetin Phytosome 500 mg) · Healthy adults aged 18–50 years, both sexes, without significant organic or psychiatric disease
500 mg1 day12
Comparison of quercetin pharmacokinetics following oral supplementation in humans
2012 · quercetin suspension · 18 healthy adults; sex and age not reported
500 mg1 day6
Comparison of quercetin pharmacokinetics following oral supplementation in humans
2012 · First Strike nutritional bars · 18 healthy adults; sex and age not reported
500 mg1 day6
Comparison of quercetin pharmacokinetics following oral supplementation in humans
2012 · RealFX Q-Plus chews · 18 healthy adults; sex and age not reported
500 mg1 day6
The variable plasma quercetin response to 12-week quercetin supplementation in humans
2010 · Q-500 · Adults aged 18–85 recruited from the community
500 mg12 weeks—
Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study
2015 · GCQID group · Japanese women and men aged 40–74 years with knee pain
90 mg16 weeks50
Acute Ingestion of a Mixed Flavonoid and Caffeine Supplement Increases Energy Expenditure and Fat Oxidation in Adult Women: A Randomized, Crossover Clinical Trial
2019 · Mixed flavonoid-caffeine (MFC) supplement · Healthy premenopausal women aged 20–47 years
208 mg1 day19
Effects of quercetin supplementation on inflammatory factors and quality of life in post-myocardial infarction patients: A double blind, placebo-controlled, randomized clinical trial
2021 · quercetin group · post-myocardial infarction patients; age and sex not stated
500 mg8 weeks44
The effect of quercetin on iron overload and inflammation in β-thalassemia major patients: A double-blind randomized clinical trial
2019 · quercetin group · Patients with β-thalassemia major; age and sex not stated
500 mg12 weeks42
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
2019 · cohort A · Adults with advanced cancer at high risk for thrombosis; age and sex not specified
500 mg8 weeks28
Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial
2016 · quercetin · healthy males aged 19–60 years with baseline plasma uric acid in the higher but healthy range
500 mg4 weeks22
Effect of quercetin on CYP3A activity in Chinese healthy participants
2012 · quercetin · healthy male volunteers; age not reported
500 mg13 days18
Effect of quercetin on P-glycoprotein transport ability in Chinese healthy subjects
2013 · quercetin · Healthy Chinese adults with different MDR1 3435 C/T genotypes
500 mg13 days18
Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment
2012 · quercetin capsules · healthy Chinese-Han male volunteers
500 mg2 weeks—
Quercetin and polycystic ovary syndrome; inflammation, hormonal parameters and pregnancy outcome: A randomized clinical trial
2023 · quercetin group · Women with polycystic ovary syndrome undergoing IVF
500 mg40 days—
Quercetins efficacy on bone and inflammatory markers, body composition, and physical function in postmenopausal women
2025 · 500 mg of quercetin (QUE) once daily · Healthy postmenopausal women
500 mg90 days—
Effect of alpha-linolenic acid in combination with the flavonol quercetin on markers of cardiovascular disease risk in healthy, non-obese adults: A randomized, double-blinded placebo-controlled crossover trial
2019 · ALA plus quercetin · Healthy, non-obese men and women; mean age 24.6 years
190 mg8 weeks—
Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial
2010 · Q-500 · Men and women aged 18–85 from the community, including people with and without chronic disease
500 mg12 weeks334
Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin
2019 · Treatment C (Quercetin Phytosome 250 mg) · Healthy adults aged 18–50 years, both sexes, without significant organic or psychiatric disease
250 mg1 day12
The variable plasma quercetin response to 12-week quercetin supplementation in humans
2010 · Q-1000 · Adults aged 18–85 recruited from the community
1 g12 weeks—
Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients
2025 · quercetin supplementation · Adults aged 18 years or older, men and women, with recent acute coronary syndrome undergoing coronary artery bypass graft surgery
1 g9 days47
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
2019 · cohort B · Adults with advanced cancer at high risk for thrombosis; age and sex not specified
1 g8 weeks29
Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans
2001 · quercetin-3-rutinoside · Healthy men and women; age not stated
440 mg7 days20
Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA
2007 · quercetin (Q) · trained male cyclists
1 g24 days20
The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity
2014 · 400 mg quercetin · Healthy volunteers, mean age 26±5 years, including women and men
400 mg1 day15
Chronic consumption of quercetin reduces erythrocytes oxidative damage: Evaluation at resting and after eccentric exercise in humans
2018 · quercetin · healthy individuals undergoing eccentric exercise
1 g2 weeks14
Quercetin Modulates IGF-I and IGF-II Levels After Eccentric Exercise-Induced Muscle-Damage: A Placebo-Controlled Study
2021 · quercetin (Q) treatment · Healthy moderately active men aged 18–30
1 g2 weeks12
Effects of Quercetin on Adiponectin-Mediated Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Double-Blind Clinical Trial
2017 · treatment group · Women with polycystic ovary syndrome (PCOS)
1 g12 weeks—
The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome
2018 · quercetin · Overweight or obese women aged 20–40 years with PCOS
1 g12 weeks—
Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial
2010 · Q-1000 · Men and women aged 18–85 from the community, including people with and without chronic disease
1 g12 weeks333
Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer
2020 · GT + Q · Men aged 43–74 with clinically localized prostate adenocarcinoma scheduled for radical prostatectomy
800 mg4 weeks15
Pharmacokinetics and bioavailability of quercetin glycosides in humans
2001 · quercetin-4'-O-glucoside · 12 healthy volunteers
100 mg1 day12
Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans
2017 · onion skin extract powder · Healthy men and women aged 21–33 years
163 mg1 day12
Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans
2017 · quercetin dihydrate · Healthy men and women aged 21–33 years
134 mg1 day12
Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides
2008 · shallot flesh · 9 volunteers; age, sex, and health status not specified
1.4 mg/kg1 day9
Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides
2008 · dry shallot skin · 9 volunteers; age, sex, and health status not specified
1.4 mg/kg1 day9
Dietary fat increases quercetin bioavailability in overweight adults
2013 · fat-free trial · Overweight or obese men and postmenopausal women at high risk for cardiovascular disease; mean age 55.9 years
1.1 g1 day9
Dietary fat increases quercetin bioavailability in overweight adults
2013 · low-fat trial · Overweight or obese men and postmenopausal women at high risk for cardiovascular disease; mean age 55.9 years
1.1 g1 day9
Dietary fat increases quercetin bioavailability in overweight adults
2013 · high-fat trial · Overweight or obese men and postmenopausal women at high risk for cardiovascular disease; mean age 55.9 years
1.1 g1 day9
Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules
2012 · quercetin-enriched cereal bars · Healthy women aged 22–28 years
130 mg1 day6
Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules
2012 · quercetin powder-filled hard capsules · Healthy women aged 22–28 years
130 mg1 day6
[Polyphenolic antioxidants in fruit juice. Urinary excretion and effects on biological markers for antioxidative status]
2000 · 750 mL juice dose · Five women and men; health status not stated
4.8 mg7 days5
[Polyphenolic antioxidants in fruit juice. Urinary excretion and effects on biological markers for antioxidative status]
2000 · 1000 mL juice dose · Five women and men; health status not stated
6.4 mg7 days5
[Polyphenolic antioxidants in fruit juice. Urinary excretion and effects on biological markers for antioxidative status]
2000 · 1500 mL juice dose · Five women and men; health status not stated
9.6 mg7 days5
Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans
2008 · Q50 · Healthy volunteers; age and sex not specified
50 mg2 weeks—
Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans
2008 · Q100 · Healthy volunteers; age and sex not specified
100 mg2 weeks—
Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans
2008 · Q150 · Healthy volunteers; age and sex not specified
150 mg2 weeks—
Effect of mixed flavonoids, n-3 fatty acids, and vitamin C on oxidative stress and antioxidant capacity before and after intense cycling
2011 · QC · Athletes; age and sex not specified
1 g17 days—
Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind, Placebo-Controlled, Crossover Trial
2015 · quercetin · Apparently healthy (pre)hypertensive men and women aged 40–80 years
160 mg4 weeks37
Quercetin, but Not Epicatechin, Decreases Plasma Concentrations of Methylglyoxal in Adults in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial with Pure Flavonoids
2018 · quercetin 3-glucoside · Apparently healthy, nonsmoking adults with systolic blood pressure between 125 and 160 mm Hg at screening
160 mg4 weeks37
Effect of quercetin on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease
2017 · research group · Adults with stable coronary heart disease, stable angina pectoris, functional class II
120 mg60 days30
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
2024 · D + Q · Postmenopausal women aged 60–90 years with T-cell p16 mRNA expression above the 95th percentile of young female controls; generally healthy
1 g20 weeks30
Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial
2024 · IQ group · Adults aged 18 years or older with steady-state sickle cell disease
1 g5 weeks23
The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity
2014 · 200 mg quercetin · Healthy volunteers, mean age 26±5 years, including women and men
200 mg1 day15
Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers
2009 · quercetin phase · 12 healthy volunteers
1.5 g7 days12
Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis
2011 · quercetin group · non-smoking, untreated patients with sarcoidosis; age and gender matched with the placebo group
2 g1 day12
Nonalcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations
2000 · quercetin group · male subjects; age and health condition not reported
30 mg2 weeks10
Effects of the flavonol quercetin and α-linolenic acid on n-3 PUFA status in metabolically healthy men and women: a randomised, double-blinded, placebo-controlled, crossover trial
2017 · ALA+quercetin · Metabolically healthy adult men and women
190 mg8 weeks—
Impact of multiple genetic polymorphisms on effects of a 4-week blueberry juice intervention on ex vivo induced lymphocytic DNA damage in human volunteers
2007 · blueberry/apple juice intervention · 168 healthy human volunteers; age and sex not reported
97 mg4 weeks168
Effect of mixed flavonoids, n-3 fatty acids, and vitamin C on oxidative stress and antioxidant capacity before and after intense cycling
2011 · QFO · Athletes; age and sex not specified
1 g17 days—
Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults
2013 · Q-1000 · Healthy adults aged 40–83 years; women and men
1 g90 days—
Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults
2013 · Q-500 · Healthy adults aged 40–83 years; women and men
500 mg90 days—
Enzymatically modified isoquercitrin in soy protein temporarily enhanced the plasma amino-acid concentrations, antioxidant index, and plasma hormone levels: a randomized, double-blind cross-over trial
2023 · Soy protein with 42 mg EMIQ · Nine healthy individuals; age range and sex not reported
42 mg7 days—
A Mixed Flavonoid-Fish Oil Supplement Induces Immune-Enhancing and Anti-Inflammatory Transcriptomic Changes in Adult Obese and Overweight Women-A Randomized Controlled Trial
2016 · Q-Mix · Women aged 40–70 years who were overweight or obese (BMI ≥25 kg/m²), without the listed major diseases
500 mg10 weeks24
Increased Plasma Levels of Gut-Derived Phenolics Linked to Walking and Running Following Two Weeks of Flavonoid Supplementation
2018 · flavonoid–walk · Healthy males and females aged 18–50 with a history of regular walking; no stated diagnosed condition
104 mg2 weeks21
Increased Plasma Levels of Gut-Derived Phenolics Linked to Walking and Running Following Two Weeks of Flavonoid Supplementation
2018 · flavonoid–sit · Healthy males and females aged 18–50 with a history of regular walking; no stated diagnosed condition
104 mg2 weeks20